Doxorubicin-loaded pH-responsive chitin nanogels for drug delivery to cancer cells

► We developed doxorubicin loaded pH responsive chitin nanogels (Dox-CNGs) for cancer drug delivery applications. ► The in vitro cytotoxicity studies of 130–160nm sized Dox-CNGs proved their cyto compatibility with L929 and toxicity towards PC3, MCF-7, A549 and HEPG2 cancer cells. ► The internalizat...

Full description

Saved in:
Bibliographic Details
Published in:Carbohydrate polymers Vol. 87; no. 3; pp. 2352 - 2356
Main Authors: Jayakumar, R., Nair, Amrita, Rejinold, N. Sanoj, Maya, S., Nair, S.V.
Format: Journal Article
Language:English
Published: Kidlington Elsevier Ltd 14-02-2012
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:► We developed doxorubicin loaded pH responsive chitin nanogels (Dox-CNGs) for cancer drug delivery applications. ► The in vitro cytotoxicity studies of 130–160nm sized Dox-CNGs proved their cyto compatibility with L929 and toxicity towards PC3, MCF-7, A549 and HEPG2 cancer cells. ► The internalization of the Dox-CNGs showed a significant uptake of the Dox-CNGs in all the tested cell lines. ► These results indicated that Dox-CNGs can be used for prostate, breast, lung and liver cancer. This work deals with preparation of doxorubicin loaded chitin nanogels and were characterized by SEM, DLS and FTIR for cancer drug delivery. The in vitro cytotoxicity studies of 130–160nm sized doxorubicin loaded chitin nanogels were studied using MTT assay on L929, PC3, MCF-7, A549 and HEPG2 confirmed that relatively higher toxicity on cancer cells comparing to normal L929 cells. The internalization studies showed a significant uptake of doxorubicin loaded chitin nanogels in all the tested cell lines. All the above results indicated that doxorubicin loaded chitin nanogels can be used for prostate, breast, lung and liver cancer.
Bibliography:http://dx.doi.org/10.1016/j.carbpol.2011.10.040
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0144-8617
1879-1344
DOI:10.1016/j.carbpol.2011.10.040